<DOC>
	<DOCNO>NCT01139567</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy optical device design develop quantitatively monitor blood flow velocity wound sit . The hypothesis blood flow velocity wound site provide critical information efficacy hyperbaric oxygen therapy .</brief_summary>
	<brief_title>Tissue Perfusion Blood Flow Monitoring Technology</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>Inclusion Criteria Subjects age 21 old follow type wound able comply study requirement : neuropathic diabetic foot ulcer soft tissue radiation necrosis crush injury compromised/failed skin graft flaps Subjects must sign Informed Consent Forms . Exclusion Criteria Subjects candidate HBO therapy reason , include limited : untreated pneumothorax , uncontrolled congestive heart failure , seizure disorder , neoplastic tumor , claustrophobia ( HBO Group ) . Female subject pregnant nursing . Anyone unable give write informed consent . Subjects endstage renal disease require peritoneal hemodialysis . Subjects current malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Diabetic Wounds</keyword>
	<keyword>Hyperbaric Oxygen</keyword>
	<keyword>Laser Speckle Imaging</keyword>
	<keyword>Hyperbaric Oxygenation</keyword>
</DOC>